Results 81 - 90 of 12671 : Previous 5 6 7 8 9 10 11 12 13 Next
Dendreon Investors: Why Shares Are Soaring
Tripling Provenge sales causes shares to soar 50%.
Can This Internet Outperformer in 2011 Find Huge Gains in 2012?
2012 could be the year XO Group's investors have been waiting for.
Mark Your Calendars, Biotech Investors
Cell Therapeutics' advisory panel meet ought to be entertaining.
This Just In: Upgrades and Downgrades
Universal Display shareholders suffer universal dismay.
This Biotech's Obese To-Do List Is Done
Arena resubmits lorcaserin for FDA approval.
2012 Preview: K-V Pharmaceuticals
Here's what the new year has in store for K-V Pharmaceuticals.
Here's Why Stratasys' Latest Report Might Worry You
Don't just ask, "How much inventory?" Ask, "What kind?"
These two simple metrics can save you a lot of pain.
Here's Why China Digital TV's Earnings Are Worse Than They Look
Don't just count the cash, time it.
Has Research In Motion Made You Any Real Money?
All cash flow is not created equal.
Results 81 - 90 of 12671 : Previous 5 6 7 8 9 10 11 12 13 Next